Safety and immunogenicity of a 9-valent HPV vaccine in females 12-26 years of age who previously received the quadrivalent HPV vaccine

Article English RESTRICTED
Garland, Suzanne M; Cheung, Tak-Hong; McNeill, Shelly; Petersen, Lone Kjeld; Romaguera, Josefina; Vazquez-Narvaez, Jorge; Bautista, Oliver; Shields, Christine; Vuocolo, Scott; Luxembourg, Alain;

<p>OBJECTIVES: To assess the safety and immunogenicity of the investigational 9-valent (6/11/16/18/31/33/45/52/58) HPV (9vHPV) vaccine in prior recipients of a 3-dose regimen of quadrivalent (6/11/16/18) HPV (qHPV) vaccine.</p><p>METHODS: V503-006 was a randomized, doub... View more
Share - Bookmark